TALLAHASSEE, Fla. - Trulieve Cannabis Corp. has received approval to list its subordinate voting shares on the New York Stock Exchange, with trading expected to begin under the ticker symbol TRLV on June 10. The move marks a significant milestone for Trulieve and the broader U.S. cannabis industry.
The company says the uplisting is expected to expand its shareholder base, improve liquidity, and increase visibility among institutional investors. Existing trading on the Canadian Securities Exchange and OTCQX markets is expected to continue through June 9 before the NYSE debut.
Industry observers have described the approval as a landmark development, with Trulieve widely regarded as the first U.S. plant-touching cannabis operator to secure a listing on a major U.S. stock exchange. The milestone follows recent federal policy shifts tied to medical-cannabis pathways and a corporate restructuring intended to satisfy exchange standards.
For investors, the NYSE listing may increase market exposure and open access to a broader institutional capital base. It may also serve as a bellwether for other major U.S. cannabis operators pursuing comparable uplisting paths as regulatory barriers continue to evolve.